These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 599413)
1. Hepatic clearance of drugs. III. Additional experimental evidence supporting the "well-stirred" model, using metabolite (MEGX) generated from lidocaine under varying hepatic blood flow rates and linear conditions in the perfused rat liver in situ preparation. Pang KS; Rowland M J Pharmacokinet Biopharm; 1977 Dec; 5(6):681-99. PubMed ID: 599413 [No Abstract] [Full Text] [Related]
2. An enzyme-distributed system for lidocaine metabolism in the perfused rat liver preparation. Pang KS; Terrell JA; Nelson SD; Feuer KF; Clements MJ; Endrenyi L J Pharmacokinet Biopharm; 1986 Apr; 14(2):107-30. PubMed ID: 3746635 [TBL] [Abstract][Full Text] [Related]
3. Hepatic clearance of drugs. II. Experimental evidence for acceptance of the "well-stirred" model over the "parallel tube" model using lidocaine in the perfused rat liver in situ preparation. Pang KS; Rowland M J Pharmacokinet Biopharm; 1977 Dec; 5(6):655-80. PubMed ID: 599412 [No Abstract] [Full Text] [Related]
4. Models of hepatic drug clearance: discrimination between the 'well stirred' and 'parallel-tube' models. Ahmad AB; Bennett PN; Rowland M J Pharm Pharmacol; 1983 Apr; 35(4):219-24. PubMed ID: 6133930 [TBL] [Abstract][Full Text] [Related]
5. Effect of endotoxin shock on the clearance of lidocaine and indocyanine green in the perfused rat liver. McKindley DS; Chichester C; Raymond R Shock; 1999 Dec; 12(6):468-72. PubMed ID: 10588516 [TBL] [Abstract][Full Text] [Related]
6. Discussions on the hepatic well-stirred model: Re-derivation from the dispersion model and re-analysis of the lidocaine data. Dong J; Park MS Eur J Pharm Sci; 2018 Nov; 124():46-60. PubMed ID: 30102979 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms of lidocaine kinetics in the isolated perfused rat liver. III. Evaluation of liver models for time-dependent behavior. Gray MR; Saville BA; Tam YK Drug Metab Dispos; 1987; 15(1):22-6. PubMed ID: 2881754 [TBL] [Abstract][Full Text] [Related]
9. Assessment of metabolic liver function and hepatic blood flow during cardiopulmonary bypass. Autschbach R; Falk V; Lange H; Oellerich M; Walther T; Mohr FW; Dalichau H Thorac Cardiovasc Surg; 1996 Apr; 44(2):76-80. PubMed ID: 8782332 [TBL] [Abstract][Full Text] [Related]
10. Effects of dl-propranolol on lidocaine disposition in the perfused rat liver. Vu VT; Chen CP Drug Metab Dispos; 1982; 10(4):350-5. PubMed ID: 6126333 [TBL] [Abstract][Full Text] [Related]
11. Mechanisms of lidocaine kinetics in the isolated perfused rat liver. II. Kinetics of steady state elimination. Saville BA; Gray MR; Tam YK Drug Metab Dispos; 1987; 15(1):17-21. PubMed ID: 2881753 [TBL] [Abstract][Full Text] [Related]
12. The effects of norepinephrine and prostaglandin E1 on pharmacokinetics of lidocaine in isolated perfused rat liver. Matsuura Y; Nishi S; Kariya N; Shimadzu K; Asada A Life Sci; 2001 Mar; 68(18):2123-9. PubMed ID: 11324717 [TBL] [Abstract][Full Text] [Related]
13. Protein Binding and Hepatic Clearance: Re-Examining the Discrimination between Models of Hepatic Clearance with Diazepam in the Isolated Perfused Rat Liver Preparation. Wang HJ; Benet LZ Drug Metab Dispos; 2019 Dec; 47(12):1397-1402. PubMed ID: 31563869 [TBL] [Abstract][Full Text] [Related]
14. The MEGX test: a tool for the real-time assessment of hepatic function. Oellerich M; Armstrong VW Ther Drug Monit; 2001 Apr; 23(2):81-92. PubMed ID: 11294522 [TBL] [Abstract][Full Text] [Related]
15. The monoethylglycinexylidide test does not correctly evaluate lidocaine metabolism after ischemic liver injury in the rat. Leclercq I; Saliez A; Wallemacq PE; Horsmans Y; Lambotte L Hepatology; 1997 Nov; 26(5):1182-8. PubMed ID: 9362360 [TBL] [Abstract][Full Text] [Related]
16. Endotoxic shock alters the pharmacokinetics of lidocaine and monoethylglycinexylidide. McKindley DS; Boulet J; Sachdeva K; Wang P; Chichester C Shock; 2002 Mar; 17(3):199-204. PubMed ID: 11900338 [TBL] [Abstract][Full Text] [Related]
17. Effect of hypoxia on the hepatic metabolism of lidocaine in the isolated perfused pig liver. Mets B; Hickman R; Allin R; Van Dyk J; Lotz Z Hepatology; 1993 Apr; 17(4):668-76. PubMed ID: 8477972 [TBL] [Abstract][Full Text] [Related]
18. The effect of SKF-525A and of altered hepatic blood flow on lidocaine clearance in the cat. Lautt WW; Skelton FS Can J Physiol Pharmacol; 1977 Feb; 55(1):7-12. PubMed ID: 843992 [TBL] [Abstract][Full Text] [Related]
19. Effects of route of administration and blood flow on hepatic drug elimination. Shand DG; Kornhauser DM; Wilkinson GR J Pharmacol Exp Ther; 1975 Dec; 195(3):424-32. PubMed ID: 1195129 [TBL] [Abstract][Full Text] [Related]
20. Lidocaine extraction by the in vivo and isolated perfused pig liver. Mets B; Hickman R; Chalton D J Hepatol; 1994 Dec; 21(6):1067-74. PubMed ID: 7699229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]